Secondary primary malignancy and radioiodine administration in differentiated thyroid cancer patients: a second check

被引：0
|
作者：
Volpe, F. [1 ]
Piscopo, L. [1 ]
Manganelli, M. [1 ]
Nappi, C. [1 ]
Zampella, E. [1 ]
Gaudieri, V. [1 ]
Volpicelli, F. [1 ]
Klain, M. [1 ]
Maurea, S. [1 ]
Cuocolo, A. [1 ]
机构：
[1] Univ Federico II, Dept Adv Biomed Sci, Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-530
引用
收藏
页码：S175 / S176
页数：2
相关论文
共 50 条
  • [31] Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
    Busaidy, Naifa Lamki
    Cabanillas, Maria E.
    JOURNAL OF THYROID RESEARCH, 2012, 2012
  • [32] Radioiodine Therapy in Patients with Stage I Differentiated Thyroid Cancer
    Jonklaas, Jacqueline
    Cooper, David S.
    Ain, Kenneth B.
    Bigos, Thomas
    Brierley, James D.
    Haugen, Bryan R.
    Ladenson, Paul W.
    Magner, James
    Ross, Douglas S.
    Skarulis, Monica C.
    Steward, David L.
    Maxon, Harry R.
    Sherman, Steven I.
    THYROID, 2010, 20 (12) : 1423 - 1424
  • [33] Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
    Cappagli, Virginia
    Caldarella, Adele
    Manneschi, Gianfranco
    Piaggi, Paolo
    Bottici, Valeria
    Agate, Laura
    Molinaro, Eleonora
    Bianchi, Francesca
    Elisei, Rossella
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (10) : 2838 - 2846
  • [34] Risk of second primary cancer following differentiated thyroid cancer
    Emmanuelle Berthe
    Michel Henry-Amar
    Jean-Jacques Michels
    Jean-Pierre Rame
    Pascaline Berthet
    Emmanuel Babin
    Philippe Icard
    Guy Samama
    Françoise Galateau-Sallé
    Jacques Mahoudeau
    Stéphane Bardet
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 685 - 691
  • [35] Risk of second primary cancer following differentiated thyroid cancer
    Berthe, E
    Henry-Amar, M
    Michels, JJ
    Rame, JP
    Berthet, P
    Babin, E
    Icard, P
    Samama, G
    Galateau-Sallé, F
    Mahoudeau, J
    Bardet, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (05) : 685 - 691
  • [36] Non-thyroidal second primary malignancy in papillary thyroid cancer patients
    Duarte, Diana Borges
    Silva, Vania Benido
    Assuncao, Guilherme
    Carvalho, Andre Couto
    Freitas, Claudia
    EUROPEAN THYROID JOURNAL, 2022, 11 (04)
  • [37] Association of Radioiodine for Differentiated Thyroid Cancer and Second Breast Cancer in Female Adolescent and Young Adult
    Zhao, Xianlan
    Chen, Mingjing
    Qi, Xiaojing
    Zhu, Haizhen
    Yang, Guangrong
    Guo, Yi
    Dong, Qiang
    Yang, Qiao
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [38] Guidelines for radioiodine therapy of differentiated thyroid cancer
    M. Luster
    S. E. Clarke
    M. Dietlein
    M. Lassmann
    P. Lind
    W. J. G. Oyen
    J. Tennvall
    E. Bombardieri
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35
  • [39] Guidelines for radioiodine therapy of differentiated thyroid cancer
    Luster, M.
    Clarke, S. E.
    Dietlein, M.
    Lassmann, M.
    Lind, P.
    Oyen, W. J. G.
    Tennvall, J.
    Bombardieri, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (10) : 1941 - 1959
  • [40] Differentiated thyroid cancer theranostics: radioiodine and beyond
    Choudhury, Partha S.
    Gupta, Manoj
    BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1091):
12345